Ayala Pharmaceuticals Inc (ADXS)

[equaloppforall]

That is factually incorrect. That $23/share is the 1-year target price of ADXS, which does not account for all of the company's pipeline or products. That number is subject to change (as all price targets are) based on reevaluation by analysts at any time. It is not an eternally fixed number that would refuse to budge in light of new developments, such as an EU application/partnership, canine vaccine approval, PSA updates etc.

Unless the company is being sold tomorrow morning, the price target our current share price are completely devoid of any significance. In certain instances, such as in the case of TBRA and CPXX, to recall recent examples, even the current share price was utterly irrelevant in the buyout evaluation.

Wouldn't you just be glad to see a buyout? What is this obsession with pre-determining a buyout price and insisting that it WILL/HAS TO be a low ball number? If it is a terrible buyout price, which I seriously doubt, there is not much that you or I could do to prevent it. But why insist on it?